The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 11, 2025

Filed:

Jan. 24, 2019
Applicants:

National Federation of Agricultural Cooperative Associations, Tokyo, JP;

Tetsuya Uchida, Saitama, JP;

Inventors:

Tetsuya Uchida, Saitama, JP;

Makoto Nakanishi, Sakura, JP;

Ryouichi Shima, Sakura, JP;

Takanori Namimatsu, Sakura, JP;

Goro Suzuki, Sakura, JP;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/385 (2006.01); A61K 39/12 (2006.01); A61K 39/215 (2006.01); A61K 47/69 (2017.01); A61P 31/14 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/385 (2013.01); A61K 39/12 (2013.01); A61K 39/215 (2013.01); A61K 47/6911 (2017.08); A61P 31/14 (2018.01); A61K 2039/545 (2013.01); A61K 2039/552 (2013.01); A61K 2039/572 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6018 (2013.01); C12N 2770/10034 (2013.01); C12N 2770/10071 (2013.01); C12N 2770/20034 (2013.01); C12N 2770/20071 (2013.01);
Abstract

Disclosed is a vaccine for non-human animals, which vaccine enables effective immune induction in non-human animals such as livestock or poultry. The vaccine for non-human animals of the present invention comprises liposomes each comprising an antigen molecule(s) bound to the surface thereof, the antigen molecule(s) being derived from a pathogen infectious to the non-human animals. The non-human animals are, for example, livestock or poultry. One most preferred example of the vaccine according to the present invention is an infectious bronchitis virus (IBV) vaccine, which is effective against various isolated IBV strains, and which is expected to be sufficiently applicable even to cases where a mutant strain appeared. Another preferred example of the vaccine according to the present invention is a PRRSV vaccine, which was confirmed to have an effect that reduces fever, lung lesion development, and the like caused by the infection. The present invention enables development of liposome vaccines effective for prevention of infections caused by various non-human animal pathogens including PRRSV as well as IBV.


Find Patent Forward Citations

Loading…